scRNA-seq Can Identify Different Cell Populations in Ovarian Cancer Bulk RNA-seq Experiments.

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• High-grade serous ovarian cancer (HGSC) is a complex, heterogeneous disease.
• Bulk tissue RNA sequencing (RNAseq) struggles to capture this heterogeneity.
• Single-cell RNA sequencing (scRNA-seq) offers a solution for analyzing diverse cellular compositions.

Purpose of the Study:

• To apply computational deconvolution methods to bulk RNAseq data from HGSC.
• To identify cell type proportions within HGSC tumors.
• To correlate these proportions with clinical outcomes and treatment responses.

Main Methods:

• Bulk RNA sequencing of 112 HGSC specimens and 12 benign fallopian tube controls.
• Utilized publicly available scRNA-seq datasets as references.
• Employed MUlti-Subject SIngle Cell Deconvolution (MuSiC) for cell type proportion estimation.
• Analyzed The Cancer Genome Atlas (TCGA) HGSC datasets.
• Correlated cell type percentages with clinical variables and treatment outcomes.

Main Results:

• Different scRNA-seq reference annotations yielded varying cell type proportions.
• Specific cellular proportions were significantly associated with clinical outcomes.
• Higher proportions of macrophages correlated with a better response to primary chemotherapy.
• Identified tumor-infiltrating cell populations potentially linked to observed clinical outcomes.

Conclusions:

• Computational deconvolution of bulk RNAseq data is a viable approach for HGSC research.
• Cellular heterogeneity in HGSC, particularly immune cell infiltration, impacts patient prognosis.
• Further investigation into specific cell populations may reveal novel therapeutic targets.